DE60035355D1 - Immunverstärkende verbindungen - Google Patents

Immunverstärkende verbindungen

Info

Publication number
DE60035355D1
DE60035355D1 DE60035355T DE60035355T DE60035355D1 DE 60035355 D1 DE60035355 D1 DE 60035355D1 DE 60035355 T DE60035355 T DE 60035355T DE 60035355 T DE60035355 T DE 60035355T DE 60035355 D1 DE60035355 D1 DE 60035355D1
Authority
DE
Germany
Prior art keywords
immuno
provides
compositions
composition
reinforcing connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60035355T
Other languages
English (en)
Other versions
DE60035355T2 (de
Inventor
Megumi Kumemura
Tatsuya Doi
Takao Saito
Tsuneyuki Noda
Hiroshi Okamatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE60035355D1 publication Critical patent/DE60035355D1/de
Application granted granted Critical
Publication of DE60035355T2 publication Critical patent/DE60035355T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE60035355T 1999-08-27 2000-08-24 Immunverstärkende verbindungen Expired - Lifetime DE60035355T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24158499A JP2001064181A (ja) 1999-08-27 1999-08-27 免疫賦活組成物
JP24158499 1999-08-27
PCT/JP2000/005655 WO2001016145A1 (fr) 1999-08-27 2000-08-24 Compositions immunostimulantes

Publications (2)

Publication Number Publication Date
DE60035355D1 true DE60035355D1 (de) 2007-08-09
DE60035355T2 DE60035355T2 (de) 2008-03-13

Family

ID=17076496

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035355T Expired - Lifetime DE60035355T2 (de) 1999-08-27 2000-08-24 Immunverstärkende verbindungen

Country Status (12)

Country Link
US (1) US6656924B1 (de)
EP (1) EP1219630B1 (de)
JP (1) JP2001064181A (de)
KR (1) KR100751865B1 (de)
CN (1) CN1371385A (de)
AT (1) ATE365743T1 (de)
AU (1) AU773079C (de)
CA (1) CA2382887C (de)
DE (1) DE60035355T2 (de)
ES (1) ES2287025T3 (de)
TW (1) TW574035B (de)
WO (1) WO2001016145A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20020078A (fi) * 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
US20040137037A1 (en) * 2002-09-27 2004-07-15 President, Shinshu University And Otsuka Pharmaceutical Co., Ltd. Plasma volume expanding formula
EP2591786B1 (de) 2003-10-16 2017-04-12 Cancure Limited Immunmodulierende Zusammensetzungen und ihre Verwendung
US7087564B2 (en) * 2004-03-05 2006-08-08 Air Liquide America, L.P. Acidic chemistry for post-CMP cleaning
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
KR20090035682A (ko) * 2006-07-19 2009-04-10 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 면역 조절제
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
JP5309404B2 (ja) 2008-05-02 2013-10-09 株式会社林原 β−フラクトフラノシド結合を有する非還元性オリゴ糖とともに還元性糖を含有するシラップ状甘味料の着色抑制方法とその利用
MX2010000660A (es) * 2009-12-11 2011-06-14 Abbott Lab Soluciones de rehidratacion oral que comprenden dextrosa.
WO2011108275A1 (ja) 2010-03-04 2011-09-09 株式会社ロッテ イムノグロブリンａ分泌促進剤
KR101153482B1 (ko) 2010-05-27 2012-06-11 오비맥주 주식회사 저칼로리 맥주 또는 맥주맛 음료의 제조방법
KR101353563B1 (ko) 2012-03-16 2014-01-23 동의대학교 산학협력단 라넬라 아쿠아틸리스로부터 유래하는 당단백질을 유효성분으로 포함하는 면역 증강용 조성물
US10570606B2 (en) * 2016-04-15 2020-02-25 Kevin Douglas Hoy Support-frameworks
JP6824222B2 (ja) * 2018-05-18 2021-02-03 サントリーホールディングス株式会社 泡保持性を有する発泡性飲料および発泡性飲料における泡保持性を改善する方法
JP7313519B1 (ja) * 2022-07-08 2023-07-24 日本甜菜製糖株式会社 ＩｇＡ産生促進剤及びＩｇＡ産生促進用の飼料組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953835B2 (ja) * 1982-08-31 1984-12-27 ビオフェルミン製薬株式会社 ビフイズス菌用選択的糖源
JP2779963B2 (ja) * 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
DE69111271T2 (de) * 1990-03-08 1996-02-22 Ensuiko Sugar Refining Verfahren zur Herstellung eines Pulvers/mit erhöhtem Gehalt an Lactosucrose und Verwendung dieses Pulvers.
JP3174611B2 (ja) * 1992-02-28 2001-06-11 明治乳業株式会社 免疫賦活組成物
JP2654529B2 (ja) * 1992-03-27 1997-09-17 大塚製薬株式会社 健康飲料組成物
DE69312851T2 (de) * 1992-04-10 1998-01-08 Otsuka Pharma Co Ltd Nahrungsmittelzusammensetzung zur hemmung von der bildung von darmverrottungsprodukten
JP2789069B2 (ja) * 1992-04-10 1998-08-20 大塚製薬株式会社 腸内腐敗産物生成抑制飲料組成物
JP3163171B2 (ja) * 1992-07-15 2001-05-08 森永乳業株式会社 ＩｇＡ産生促進剤
JPH06327435A (ja) * 1992-11-10 1994-11-29 Otsuka Pharmaceut Co Ltd 栄養補給組成物
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
AUPN881396A0 (en) * 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
JPH09299059A (ja) * 1996-05-17 1997-11-25 Uehara:Kk 整腸用飲食物
JPH10108647A (ja) * 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
JP2931797B2 (ja) * 1996-12-25 1999-08-09 武男 若桑 ダイエット飲料
JPH10265390A (ja) * 1997-03-27 1998-10-06 Hayashibara Biochem Lab Inc 腹部異常抑制用組成物
JPH1057092A (ja) * 1997-04-09 1998-03-03 Hayashibara Biochem Lab Inc ラクトスクロース高含有物とその製造方法並びに用途
EP1046347B1 (de) * 1998-01-08 2003-11-26 Otsuka Foods Co., Ltd. Gelierte nahrungsmittel sowie verfahren zu deren herstellung
WO2000045830A1 (fr) * 1999-02-04 2000-08-10 Nichimo Co., Ltd. Substances permettant d'eviter la survenue de l'arteriosclerose, substances immunostimulantes, vertebres nourris a l'aide ces substances et oeufs de ces vertebres

Also Published As

Publication number Publication date
EP1219630B1 (de) 2007-06-27
TW574035B (en) 2004-02-01
KR20020068499A (ko) 2002-08-27
KR100751865B1 (ko) 2007-08-23
CA2382887A1 (en) 2001-03-08
CN1371385A (zh) 2002-09-25
US6656924B1 (en) 2003-12-02
AU6726800A (en) 2001-03-26
EP1219630A4 (de) 2004-05-26
CA2382887C (en) 2011-02-01
AU773079C (en) 2005-07-21
WO2001016145A1 (fr) 2001-03-08
DE60035355T2 (de) 2008-03-13
AU773079B2 (en) 2004-05-13
JP2001064181A (ja) 2001-03-13
EP1219630A1 (de) 2002-07-03
ATE365743T1 (de) 2007-07-15
ES2287025T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
DE60035355D1 (de) Immunverstärkende verbindungen
WO2003045331A3 (en) Formulations for oral administration of cromolyn sodium
BR9807076A (pt) Tratamento de esclerose múltipla mediante ingestão ou inalação de copolìmero-1
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
DE69428122D1 (de) Phosphatbindende polymere für orale verabreichung
CA2321523A1 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
PT994710E (pt) Composicoes farmaceuticas administraveis por via oral incluindo uma benzidrilpiperazina e uma ciclodextrina
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
FR2762843B1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
HUP0201631A2 (hu) Alkalikus szfingomielinázt tartalmazó dietetikus készítmények, ételkiegészítők és gyógyászati termékek
DK1057828T3 (da) Orale trovafloxacin-suspensioner
HUP0105481A2 (hu) Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
CA2386423A1 (en) Pharmaceutical compositions containing copper, salicylic acid and vitamines c
ATE238034T1 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
CA2429793A1 (en) Interferon therapeutic effect enhancer
EP1273301A3 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung bieten
DE60214881D1 (de) Zubereitungen zur behandlung von lupus
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
DE69902925T2 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
CA2391297A1 (en) 6-o-alkyl-2-nor-2-substituted ketolide derivatives
WO2003004096A3 (en) Method and composition for prolonging the residence time of drugs in the gut
IT1254688B (it) Composizioni farmaceutiche somministrabili per via orale a rilascio mirato contenenti acido ursodesossicolico ed acido chenodesossicolico.
BR0100292A (pt) Composição de medicamentos a base da cássia occidentalis e aveia integral

Legal Events

Date Code Title Description
8364 No opposition during term of opposition